Psilocybin Paper Corrected; Fewer Psychiatrists Billing Medicare; Cannabis and Death

A 2024 meta-analysis on psilocybin’s effects on depression published in The BMJ was corrected earlier this week following methodological errors, but conclusions indicating a benefit remain unchanged.

A study showed that manic symptoms were present in about 27% of stable outpatients with schizophrenia spectrum disorders. (Brain Medicine)

Early treatment of attention deficit-hyperactivity disorder (ADHD) in kids may reduce their risk of smoking or vaping later on, a cohort study suggested. (JAMA Network Open)

From 2014 to 2022, the number of psychiatrists billing Medicare Part B declined, while the total number of active psychiatrists increased, according to a cross-sectional study. (JAMA Network Open)

A study suggested that self-reported mental health had a clear association with time of day, with people generally feeling best after waking up and worst around midnight. (BMJ Mental Health)

Research from Canada linked cannabis use disorder with a higher risk of death. (JAMA Network Open)

A start-up called LinusBio launched a test that it says can help physicians rule out autism in children, using a strand of hair. (NBC News)

Co-occurring ADHD and autism among adults was associated with worse health outcomes, but ADHD medication prescriptions were generally tied to better health outcomes. (JAMA Network Open)

Researchers pinpointed a common functional circuit aligning with the posterior subiculum of the hippocampus that may be causally tied to psychosis. (JAMA Psychiatry)

A Colorado bill would make it harder for insurance companies to deny mental health coverage. (CBS News)

Stress about eviction or housing loss was linked to a higher risk for depression, but not anxiety, in children, especially younger kids, in a cross-sectional study. (JAMA Network Open)

Please enable JavaScript to view the

comments powered by Disqus.